VYNE Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: VYNE Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: VYNE Therapeutics Inc
Rating: 1.78150
Author: Trendlyne DVM scores

about

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated fo...

0.58 -0.01 (-1.69%)

75.73% Fall from 52W High

54,033

XNAS Volume

XNAS 05 Mar, 2026 4:30 PM (EST)

Board Meeting

The board meeting for VYNE Therapeutics Inc is scheduled for today, for the purpose of VYNE Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

18.5 / 100

Technically Neutral

52.8 / 100

1Yr Price target upside is 245%

1 analysts

VYNE Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VYNE Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated fo...

75.73% Fall from 52W High

SWOT Analysis

VYNE Therapeutics Inc Live Price Chart